Interview Bert Arjan Millenaar with Paul van Liempt

https://nlc-health.webflow.io/news/interview-bert-arjan-millenaar-with-paul-van-liempt

Anne Reijns

Jun 2019

•

5 min read

Anne Reijns

Jun 2019

•

5 min read

Read article on external website

Interview (in Dutch but subtitled in English) with Paul van Liempt, explaining the NLC – The Healthtech Venture Builder way of bringing science to life.

Insights

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Dutch health insurer VGZ invests in NLC Health Ventures

Dutch health insurer VGZ invests in NLC Health Ventures

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

NLC completes first close of €100 million health impact fund

NLC completes first close of €100 million health impact fund

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

Introducing Aerion Bioscience: A new era of cancer screening

Introducing Aerion Bioscience: A new era of cancer screening

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

POROUS wins innovation award

POROUS wins innovation award

Ansana secures a €850,000 investment

Ansana secures a €850,000 investment

Introducing LiftYa: Stability with motion

Introducing LiftYa: Stability with motion

Introducing StarTric: Transcatheter tricuspid heart valve repair

Introducing StarTric: Transcatheter tricuspid heart valve repair

Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions

Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted.

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted.

Introducing our newest venture ChARM: Empowering low-resource healthcare professionals around the world

Introducing our newest venture ChARM: Empowering low-resource healthcare professionals around the world

Introducing our newest venture: Asclepius

Introducing our newest venture: Asclepius

Introducing our venture Nilocas: A cardiac device for the detection of coronary artery disease

Introducing our venture Nilocas: A cardiac device for the detection of coronary artery disease